Andreas L. Kjaer
Copenhagen, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 560 publications
SSTR-PeRForm: A harmonized approach to somatostatin receptor PET response assessment in neuroendocrine tumors.
Journal: Journal of neuroendocrinology
Published: July 30, 2026
New Section: Forensic Diagnostics.
Journal: Diagnostics (Basel, Switzerland)
Published: April 30, 2026
Multi-Vendor and Multi-Site Characterization of 13C Coils for Clinical Studies.
Journal: Magnetic resonance in medicine
Published: April 27, 2026
Controversies in NEN: An ENETS position statement on the interchangeability of somatostatin receptor PET tracers.
Journal: Journal of neuroendocrinology
Published: April 25, 2026
Establishing normal myocardial blood flow and myocardial flow reserve values: a rubidium-82 positron emission tomography study.
Journal: European journal of nuclear medicine and molecular imaging
Published: April 01, 2026
Evaluating the Translation Value of Two In Vivo Models for Breast Cancer Brain Metastases.
Journal: Cancers
Published: February 24, 2026
In Vivo Comparison of Site-Specific and Site-Selective Methods for Pretargeted Imaging in a Murine Model of Colorectal Cancer.
Journal: Molecular pharmaceutics
Published: February 18, 2026
Comparative evaluation of iodinated, nanoparticle-based, and gadolinium-based contrast agents in computed tomography for small animals.
Journal: PloS one
Published: January 25, 2026
Endoscopic or Open Radial Artery Harvest in Coronary Artery Bypass Surgery.
Journal: NEJM evidence
Published: December 23, 2025
Somatostatin receptor PET response assessment framework for patients with neuroendocrine tumours (V1.0): a modified Delphi consensus from the European Neuroendocrine Tumor Society (endorsed by EANM and NANETS).
Journal: The Lancet. Oncology
Published: December 22, 2025
64Cu-DOTATATE-PET/CT in Neuroborreliosis Shows Increased Tracer Uptake in Dorsal Root and Paravertebral Ganglia.
Journal: Diagnostics (Basel, Switzerland)
Published: December 16, 2025
Semaglutide and Early-Stage Metabolic Abnormalities in Individuals With Schizophrenia Spectrum Disorders: A Randomized Clinical Trial.
Journal: JAMA psychiatry
Published: December 03, 2025
Last Updated: 09/26/2026